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Abstract  
OipA, outer inflammatory protein A, is an outer membrane protein virulence factor of the 
gastric pathogen Helicobacter pylori. oipA expression is regulated by phase variation at a CT 
dinucleotide repeat located within the 5’ end of the gene, such that the gene is alternatively in-
frame (Phase On) or out-of-frame (Phase Off). H. pylori isolates lacking the cag Pathogenicity 
Island (cagPAI negative), the primary virulence determinant of H. pylori, induce less host 
inflammation and almost uniformly possess an oipA allele that is phase off. Meanwhile, cagPAI 
positive H. pylori isolates almost always possess phase on oipA alleles.  The cagPAI encodes a 
type IV secretion system (T4SS) that elicits the secretion of the pro-inflammatory cytokine, 
Interleukin 8 (IL-8), by infected gastric epithelial cells. OipA has been shown to play a role in 
inflammation and as an adhesin that assists in the attachment of H. pylori to host cells. Based on 
the current study, we hypothesize that the highly conserved, albeit apparently non-expressed, 
oipA in cagPAI negative strains can affect the adherence character of these isolates of reduced 
virulence when altered to a phase on status; however OipA’s role in inflammation may be 
dependent upon the presence of the cagPAI.  
We sought to determine the role of OipA in cagPAI positive and negative H. pylori 
infection of human gastric adenocarcinoma (AGS) cells using the cagPAI positive strain, 26695, 
and cagPAI negative strains, J68 and J75. The oipA CT repeat length was experimentally altered 
in H. pylori 26695 in order to turn oipA phase off, and turn oipA phase on in J68 and J75. Real 
time quantitative PCR (RT-qPCR) was used to determine the relative quantity of oipA mRNA. 
Experimentally turning oipA phase off in strain 26695 resulted in a >5-fold decrease in oipA 
transcript levels compared to the wild type.   The novel phase on oipA J68 mutant resulted in a 
	 	 	 	 				 	  
>6-fold increase in oipA transcription, and Western blotting using antibodies to a FLAG epitope 
tagged inserted within the J68 oipA allele revealed protein expression at the whole cell level.  
AGS attachment assays revealed that H. pylori adherence was significantly increased in 
both the cagPAI positive and negative strain when oipA was phase on compared to isogenic oipA 
phase off strains. Quantification of IL-8 by enzyme-linked immunosorbent assay showed that 
this variation in H. pylori attachment was only linked to changes in IL-8 production by AGS 
cells when infected by the cagPAI positive strain, not cagPAI negative. Taken together, these 
results indicate that oipA, although phase off in cagPAI negative isolates of H.pylori, can still 
serve as an adhesin independent of a cag T4SS. However, both OipA and the cagPAI are 
necessary to induce the host pro-inflammatory cytokine response.  
Using RT-qPCR, we quantified oipA transcription in response to attachment of H. pylori 
to AGS cells.  oipA transcript levels were at least 7-fold higher in the H. pylori cells attached to 
AGS cells compared to non-adherent H. pylori cells from the same experiments.  This apparent 
attachment selection favoring bacteria expressing higher levels of oipA was found in both phase 
on and phase off mutants of the cagPAI positive strain 26695. This finding further adds to the 
role OipA plays in attachment to host cells.  
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Introduction 
Helicobacter pylori  
 In 1982 researchers Barry Marshall and Robin Warren challenged the common 
perception that gastric ulcers were caused by stress. Beginning with Marshall’s self-ingestion 
experiments with samples isolated from patients, which resulted in transient gastritis, they 
proved A) that the stomach is not a sterile environment as previously thought, and B) that the 
isolated bacterial species, Helicobacter pylori, is the etiological agent of Peptic Ulcer Disease 
and other gastric ailments including gastric cancer. For their work, Marshall and Warren were 
awarded with the 2005 Nobel Prize in Physiology or Medicine (Nobel Media 2014).  
 Further characterization revealed that H. pylori is a gram negative spiral shaped bacterial 
species (Marshall & Warren 1984). H. pylori resides exclusively in the human stomach and has 
been associated with chronic gastritis, gastric ulcers, duodenal ulcers, and gastric cancer. The 
exact mode of transmission is largely unknown, but it typically occurs in childhood, either via 
vertical transmission from mother to child, or via oral-oral or fecal-oral routes (Brown 2000). 
While more than half of the world’s population is infected with H. pylori in their upper 
gastrointestinal tract, over 80% of those hosts show no negative symptoms (Blaser 2006). In fact, 
studies have shown that this infection has the potential to confer desirable effects such as 
resistance to acid reflux disease and to childhood asthma (Lim et al. 2016), and it is thought that 
H. pylori may play an important role in the natural flora of the stomach. While the prevalence of 
this bacterium is decreasing with the rise of antibiotic use in Western countries, H. pylori 
colonization is still widespread in the developing world (Gerrits et al. 2017). 
 Though not always problematic, gastric colonization by H. pylori can have many 
detrimental effects and impacts the lives of many. In fact, the World Health Organization (WHO) 
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listed clarithromycin resistant H. pylori as a “high priority” member of its 2017 list of bacteria 
for which new antibiotics are urgently needed (Branswell 2017). With pervasive antibiotic use 
and a concomitant increase in antibiotic resistance in many H. pylori strains, it is important to 
continue studies of its pathogenesis and mechanisms of persistence in the stomach in order to 
develop novel treatments. 
H. pylori Persistence in the Stomach 
Prior to the studies of Marshall & Warren less than 40 years ago, it was thought that the 
stomach was a nearly germ-free environment, and that the only microbes inhabiting it were 
remnants from food and oral microbiota (Nardone & Compare 2015). This belief stemmed from 
the lack of perceived ability of microbes to withstand the hostile environment of the stomach, 
including low pH levels, proteolytic enzymes, and shedding of the gastric mucus and underlying 
epithelial cells. H. pylori’s ability to not only reside in the stomach, but to persist, often over the 
entire lifespan of the host, and to cause chronic illness and even cancer, has only recently begun 
to be understood.  
The acidic nature of the stomach is one of the preliminary features of the innate immune 
response and inhibits the growth of the vast majority of pathogens that might find their way into 
the stomach. In fact, it is likely a key factor in protecting more distal portions of the 
gastrointestinal tract from infection by pathogenic bacteria, viruses, and parasites (Smith 2003).  
Using chemotaxis, H. pylori is able to sense the pH gradient as it burrows through the mucus 
layer using its flagella, and moves towards the less acidic epithelial cells underneath the mucus 
(Rolig et al. 2012). H. pylori also has the ability to neutralize the acid in its immediate vicinity 
by producing urease, which breaks down urea to carbon dioxide and ammonia which can react 
with strong acids to produce a neutral environment immediately surrounding the bacterium 
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(Schreiber et al. 2004; Suzuki et al. 2002). The bacterium can then live freely in the mucus or 
adhere to gastric epithelial cells via a variety of outer membrane proteins. Two particularly well-
documented adhesins include SabA and BabA, which play a role in sialic acid-binding and blood 
group antigen-binding, respectively (Yamaoka 2008; Ishijima et al. 2011).  
This adherence function also helps the bacterium persist in the face of a second major 
barrier to colonization- the shedding of the mucus lining. However, in a given population of H. 
pylori in the stomach, only a small percentage adheres to the epithelial cell surfaces at a given 
time, while the majority are motile in the mucus layer. The adherent cells are more efficient in 
the delivery of bacterial proteins into host cells (Oleastro & Ménard 2013). Without these 
functions, chronic colonization would not be possible.  
H. pylori pathogenesis   
The global prevalence of H. pylori infection is about 50% of the population, making it the 
most widespread infection in the world. However, in many developing countries, more than 80% 
of the population may be H. pylori positive (Khalifa et al. 2010). Prevalence is less than 40% in 
industrialized countries, and that number continues to decrease due to antibiotic use, access to 
adequate health care, and emphasis on hygiene (Nagy et al. 2016). While most people never 
show symptoms of H. pylori colonization, in some individuals it is associated with peptic ulcers 
as well as gastric cancer.  
Infection of H. pylori in the stomach can result in chronic gastritis, or inflammation of the 
stomach lining, mainly caused by an induced host inflammatory response at the site of infection 
(Kusters et al. 2006). Additionally, the ammonia produced as H. pylori regulates pH is toxic to 
epithelial cells, and additional H. pylori proteins such as VacA (vacuolating cytotoxin A) can 
disrupt tight junctions and lead to damage in epithelial cells, and even cause apoptosis 
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(Palframan et al. 2012). Chronic gastritis may progress to peptic ulcer disease when the epithelial 
layer of the stomach is broken down by the inflammatory response and stomach acid and pepsin 
are able to penetrate and damage tissue (Dumrese et al. 2009). 
Gastric cancer is the fourth most common cause of cancer related death in the world 
(WHO 2017). H. pylori positive individuals develop gastric cancer more often than uninfected 
individuals, and H. pylori infection increases the risk of gastric cancer by a minimum of ten-fold 
(Wroblewski et al. 2010). Additionally, H. pylori has been designated a class I carcinogen by the 
WHO, making it a rare “living carcinogen.” It is estimated that in the developed world, up to 
75% of gastric cancers are related to chronic H. pylori infection (Suganuma et al. 2012). While 
the exact mechanism by which H. pylori causes cancer is not known, one proposed mechanism 
suggests that the enhanced production of free radicals at the site of infection contributes to an 
increased rate of host cell mutation (Sepulveda 2013). Another mechanism proposes a 
transformation of the host cell phenotype via interactions with the bacterium. This “perigenetic 
pathway” suggests that prolonged inflammatory response can alter gastric epithelial cell-cell 
adhesion and dispersion without changes in tumor suppressor genes (Tsuji et al. 2003). 
Additionally, infection with strains of H. pylori containing a crucial virulence locus, the cag 
Pathogenicity Island, and thus the oncogenic protein cytotoxin-associated antigen A (CagA), is 
strongly associated with gastric cancer (Hatakeyama 2004).  
The cag Pathogenicity Island  
 Pathogenicity islands (PAIs) are mobile genetic elements involved in the virulence of 
bacterial pathogens and are acquired through horizontal gene transfer (Juhas 2015). Horizontal 
gene transfer is the means by which genetic material is transferred between microorganisms, 
other than from parent to offspring. This process can occur via plasmids, or small DNA 
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molecules separate from chromosomal DNA (transformation), via bacteriophage (transduction), 
or via conjugative transposons (conjugation) (Zhaxybayeva & Doolittle 2011). Often PAIs 
encode proteins involved in virulence; in fact, this is one means by which bacteria pass on 
antibiotic resistance genes, a major challenge in modern medicine (Schmidt & Hensel 2004).  
 The cagPAI of H. pylori is a 40-kb chromosomal region, identifiable due to a lower GC 
content, 29.6%, compared to the rest of the genome, 39% (Terry et al. 2005). The cagPAI 
encodes a type IV secretion system (T4SS), and its presence in the H. pylori genome is positively 
associated with the presence of highly active alleles of the secreted Vacuolating Cytotoxin 
(VacA). VacA is shown to enhance colonization and pathogenesis by means such as stimulation 
of vacuole formation in host cells (Foegeding et al. 2016). The name of the cagPAI stems from 
the gene for its effector protein, CagA, or cytotoxin associated gene A. There are 31 open 
reading frames in the PAI, and cagA is located on the 3’ end of the island. CagA is translocated 
into host stomach epithelial cells via the T4SS, also encoded within the cagPAI, upon attachment 
(Noto & Peek 2012). These secretion systems involve conjugative structures to transport proteins 
through a complex channel structure directly through the membrane into the cytoplasm of the 
host cell (Backert & Tegtmeyer 2017). Chaperones stabilize effectors like CagA, and energize 
protein export by ATP hydrolysis. Once inside the cell, CagA is phosphorylated by a host kinase, 
and proceeds to interact with systems leading to host cell junction damage, cytoskeletal changes, 
and cell proliferation (Figure 1A) (Hatakeyama 2008).  
In a separate sequence of events, non-translocated proteins of the T4SS encoded by the 
cagPAI are involved in inducing pro-inflammatory cytokine, most importantly Interleukin 8 (IL-
8), production by host cells (Figure 1A) (Fischer et al. 2002). This pro-inflammatory response 
depends on the activation of transcription factor NFκB. Gastric epithelial cells secrete IL-8 in 
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order to recruit an innate immune system response, resulting in strong inflammation in the 
gastric mucosa. The cagPAI is found disproportionately in H. pylori isolates from patients with 
chronic active gastritis, peptic ulcer disease, and gastric cancer, indicating that it is an important 
virulence factor in the bacterium (Cover 2016). Thus, cagPAI positive strains containing the PAI 
are naturally more virulent, while cagPAI negative strains lacking the island are naturally much 
less virulent.  
Outer Membrane Inflammatory Protein A  
 Outer membrane inflammatory protein A, or OipA, is an outer membrane protein unique 
to H. pylori.  Approximately 4% of the H. pylori genome encodes for a large set of outer 
membrane proteins (OMPs), many with unique functions including adhesion and pH regulation 
(Oleastro & Ménard 2013). OipA, encoded by the gene oipA (previously hopH – HP0638), is 
originally named for its role in inducing inflammation in the host, as evidenced by high mucosal 
IL-8 levels. The particular means by which OipA induces inflammation are unclear as the 
evidence often overlaps with cagPAI-mediated pathways (Figure 1B). It is hypothesized that IL-
8 gene transcription related to OipA involves the transcription factor NFκB, activator protein 1, 
and an interferon-stimulated responsive element within the IL-8 promoter (Yamaoka 2010).  
OipA is now known to play roles in adherence to host cells and host colonization, in 
addition to promoting host inflammation (Figure 1B) (Dossumbekova et al. 2006). OipA is a 
member of the Hop (Helicobacter Outer Proteins) outer membrane family of proteins, all of 
which promote binding to the gastric epithelium in some way (Oleastro & Ménard 2013). 
Regarding the role of OipA in adhesion, the host gastric epithelial cell receptor is unknown, but 
has been hypothesized to be in the integrin family, which normally mediate cell-cell interactions 
(Posselt et al. 2013).  
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OipA is a protein ~ 34 kDa in size encoded by the gene oipA, which exhibits phase 
variation that is regulated by slipped strand mispairing within a hypermutable CT dinucleotide 
repeat motif located in the 5’ region of the gene (Miftahussurur & Yamaoka 2015). Slipped 
strand mispairing is a mutagenic process that occurs during DNA replication when DNA strands 
are displaced, resulting in the mispairing of complementary bases (Torres-Cruz & van der 
Woude 2003). This mechanism is most common in repetitive DNA sequences, such as the CT 
tract in oipA, and typically involves the deletion or insertion of one repeat unit. Such changes in 
oipA result in a frame shift that drives phase variation in protein expression. While there is great 
variation in the number of CT’s in the dinucleotide repeat of oipA between strains, slipped strand 
mispairing within strains of H. pylori grown in vitro is very rare compared to other outer 
membrane protein genes, such as sabA (Yamaoka et al. 2006).  
The number of CT repeats determines whether the open reading frame is in or out of 
frame to be translated into a full-length functional OipA protein, thus phase on or phase off, 
respectively. In a study of 410 H. pylori patient isolates, it was found that this CT sequence can 
range from 3 to 12 repeats, with short repeats predominating in Eastern Asian countries, where 
gastric cancer caused by H. pylori is much more prevalent compared to strains from Western 
countries (Yamaoka et al. 2002). Studies show that a functional “phase on” status of oipA is 
associated with increased risk for peptic ulcer disease and gastric cancer. The strong correlation 
of functional OipA and the virulence of the bacterium has made OipA a candidate for potential 
vaccines against H. pylori (Chen et al. 2002). Additionally, functional OipA is significantly 
associated with high H. pylori density in infected stomachs and severe neutrophil infiltration (Liu 
et al. 2013). 
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Figure 1.  The pathogenesis of CagA (A) and OipA (B) signaling in host gastric epithelial 
cells. CagA is translocated into host cells via a T4SS encoded by the cagPAI. CagA causes 
proliferation and inflammation, as does OipA, in addition to its role as an adhesin. If and how 
OipA works in conjunction with the T4SS or CagA to induce inflammation is widely unknown. 
(Adapted from Yamaoka 2010) 
A	
B	
Cell membrane 
Cell membrane 
CagA & the Type IV 
Secretion System  
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The relationship between OipA and the cagPAI  
 OipA and the cagPAI are two important H. pylori virulence factors and there is great 
interest in the relationship they have to each other. Interestingly, Ando et al. (2002) confirmed 
that while the vast majority (>96%) of cagPAI positive isolates contained oipA “phase on,” 0% 
of cagPAI negative isolates contained the gene in its phase on status, yet the gene was always 
present and highly conserved. With such relatively small genomes, it is rare for a bacterial 
genome to contain extraneous genetic information that is not expressed or somehow utilized. 
While OipA and the cagPAI are both known to induce the secretion of cytokines such as IL-8 by 
host epithelial cells, most likely via a mechanism involving transcription factor NF-κB, how they 
work together (or if they work together) is widely unknown (Matsuo et al. 2017). The present 
study aims in part to determine the relationship between oipA and the cagPAI, and to shed light 
on why oipA is so highly conserved in cagPAI negative strains in which the protein is apparently 
not expressed.  
Objectives 
 The first step in resolving the question of why oipA is present in cagPAI negative strains 
of H. pylori, yet seemingly never expressed, is to determine a) if it is possible to artificially alter 
the expression of the gene oipA and b) document and quantify any impacts of OipA expression 
on H. pylori phenotypes. In silico correction of the CT repeat tract in oipA indicates that cagPAI 
negative isolates of H. pylori are capable of producing a protein with >95% amino acid identity 
to orthologs from cagPAI positive isolates (Figure 2). Based on this, a primary objective of this 
study was to alter the poly CT tract of oipA in the cagPAI negative strains J68 and J75 in order to 
turn oipA “phase on,” and conversely, to alter the poly CT tract of oipA in the cagPAI positive 
strain 26695 in order to turn it “phase off.”  A second objective was to quantify changes in oipA 
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expression subsequent to 
experimental phase shifts by 
using real time quantitative 
PCR and Western Blots. The 
third objective of this project 
was an analysis of the effects 
of these changes on virulence 
phenotypes when mutant 
strains were used to infect 
gastric adenocarcinoma cells 
(AGS cells). The virulence 
phenotypes analyzed included the bacterium’s ability to adhere to host cells, quantified using 
attachment assays to a cultured gastric cell line in vitro, as well as the ability of these infected 
cells to produce pro-inflammatory cytokines, such as IL-8, in response to infection with these 
oipA mutants.  
 Our hypothesis was that by altering the poly CT tract to turn oipA phase on in the cagPAI 
negative strains J68 and J75, transcript levels of the gene would increase, and a functional 
protein would be produced. Additionally, when used to subsequently infect AGS cells, these 
mutants would display increased attachment ability, and induce greater IL-8 production by host 
cells. We hypothesized the opposite results when using a mutant where we experimentally turned 
oipA “phase off” in the cagPAI positive strain 26695.  
 
 
Figure 2. OipA is highly conserved in four different strains 
of H. pylori. The amino acid sequences of OipA after in silico 
correction of the gene to phase on status in 3 cagPAI negative strains 
were compared to OipA in the cagPAI positive strain, 26695 (A), via 
ClusalW alignment. The cagPAI negative strains are: B) J68, C) J75, 
and D) J195.  
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Materials and Methods 
H. pylori culture  
 H. pylori was cultured on tryptic soy agar II with 5% sheep’s blood, otherwise known as 
blood agar plates (BAPs) from BBL for 24-72 hours at 37°C in an ambient air/5% CO2 
atmosphere. Liquid cultures of H. pylori were grown in sulfite-free Brucella broth (SFBB) 
supplemented with 1X cholesterol (Gibco by Life Technologies), and 20 µg vancomycin/mL 
shaking at 150 rpm.  
AGS cell culture 
 AGS cells were a gift from Timothy Cover of Vanderbilt University Medical Center. 
Cells were grown in Roswell Park Memorial Institute (RPMI) medium 1640 supplemented with 
HEPES (Gibco by Life Technologies), 10% fetal bovine calf serum (FBS) or newborn calf serum 
(NCS), and penicillin/streptomycin (P/S). Cultures were grown at 37°C in an ambient air/5% 
CO2 atmosphere on either 6-well tissue culture treated plates (CytoOne) or T-75 tissue culture 
flasks (PRIMARIA by Fischer Scientific).  
Cloning of metronidazole resistant plasmids 
 In creating the oipA mutant strains of H. pylori, an antibiotic counter-selection method 
designed by Mark McClain at Vanderbilt University Medical Center (Loh et al. 2011) was 
employed with the goal of introducing a specific mutation into the gene without leaving any 
antibiotic resistance genes behind. While a traditional method of inserting mutations involves 
attaching the desired alteration to an antibiotic resistance gene, this also introduces the possibility 
that any phenotypic changes observed may be due to the presence of the resistance gene.  
 The first step of this method was to create a metronidazole resistant (MtzR) strain of both 
the cagPAI positive strain of H. pylori 26695, and the cagPAI negative strains J68 and J75. 
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Unless otherwise specified, all plasmids and H. pylori mutants regarding the strain J68 were 
created by another student in the Forsyth lab, Allison Begley (Unpublished data 2016). 
Metronidizole is a pro-drug that must be reduced by a bacterial enzyme in order to become 
bacteriocidal. In H. pylori RdxA  is the enzyme that accomplishes this reduction. Thus, deleting 
an internal portion of rdxA, and thereby rendering it non-functional, generates an H. pylori MtzR 
mutant.  
This was accomplished by first amplifying a 1556 bp amplicon containing the full length 
rdxA gene (HP0954) using the HP0955 Fwd and HP0953 Rev primers (Table 1) in a standard 
PCR. All primers were synthesized by Integrated DNA Technologies unless otherwise specified. 
The amplicon was cloned into a TOPO TA cloning vector pCR4 (Invitrogen) according to the 
manufacturer’s protocol. The resultant plasmids isolated from E. coli were named prdxA (Table 
2). 
Inverse PCR was performed on these plasmids to delete a 390bp internal portion of rdxA 
using the iPCR rdxA Fwd and Rev primers (Table 1) with 5’ phosphorylation to aid in ligation. 
The resultant linear product was checked for size on an agarose gel, the PCR product was 
purified using a spin column kit for PCR Purification (IBI) and digested with DpnI restriction 
endonuclease to destroy the prdxA template, and then ligated together using T4 DNA ligase 
(Quick Ligation Kit - New England Biolabs) and transformed into E. coli DH5α competent cells 
and selection for ampicillin resistance was used to isolate clones containing the mutant plasmid. 
Clones were screened by purifying and isolating plasmids, which were screened via PCR using 
the HP0955 Fwd and HP0953 Rev primers and compared to the amplicons generated from the 
parental plasmid prdxA. Successful deletions were identified by a decrease in amplicon size of 
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390 bp and confirmed via sequencing reactions performed using the Big Dye Sequencing Kit 
(Applied Biosystems), and the successful plasmid construct was named pΔrdxA (Table 2).  
The confirmed ΔrdxA plasmid was used in natural transformation of the H. pylori strains 
26695, J68, and J75. MtzR colonies capable of growing on 5µg metronidazole/mL SFBB 10% 
NCS plates were selected, and the mutation was confirmed by performing PCR on extracted 
gDNA using the HP0955 Fwd and HP0953 Rev primers and performing agarose gel 
electrophoresis to confirm the presence of a deletion. The deletion was further confirmed with 
sequencing reactions performed using Big Dye (Invitrogen) with the primer HP0955 Fwd, and 
strains were named 26695, J68, and J75 ΔrdxA, respectively (Table 3).  
Cloning of rdxA complement / chloramphenicol resistant plasmids 
 Separately from the MtzR clones, a chloramphenicol (Cm) resistance gene (CAT or 
chloramphenicol acetyl transferase) together with an intact version of rdxA as a cassette, was 
inserted into the oipA gene in 26695, J68, and J75. The purpose of this cassette insertion is 
twofold. One, it will serve as a traditional “knock out” or null mutation of the oipA gene, as the 
large cassette will prevent functionality of the gene product. Two, placing an intact, functional 
copy of rdxA within oipA will return Mtz sensitivity to H. pylori, while simultaneously adding 
the CAT gene will confer Cm resistance. Thus, in a subsequent natural transformation/ allelic 
exchange reaction, when a mutant ΔoipA plasmid is naturally transformed into strains of H. 
pylori with both the rdxA deletion, and the CAT-rdxA cassette, the mutant ΔoipA allele can 
recombine to replace the oipA::CAT-rdxA cassette, and the ΔrdxA mutant can be selected for as 
those clones will return to a MtzR phenotype.   
 The first step in this process was to amplify a region containing the entire oipA gene, as 
well as the untranslated regions both upstream and downstream, in a PCR using the oipA 
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universal Fwd and Rev primers designed based on a consensus sequence built from N=4 H. 
pylori sequenced genomes (Table 1). The resultant amplicon of ~2300bp was cloned into the 
TOPO TA cloning vector, pCR4 (Invitrogen), and the resultant plasmid was named pOipA 
(Table 2). Next, the GeneArt Site-Directed Mutagenesis System (Invitrogen) was utilized 
according to the manufacturer’s protocol to insert a BamHI site into the cloned allele of oipA 
using the oipA BamHI Fwd and Rev mutagenic oligos (Table 1). Mutagenesis reaction products 
were used to transform XL10-Gold Competent E. coli cells and clones were selected for using 
ampicillin resistance and screened with Big Dye (Invitrogen) sequencing. This plasmid was 
named pOipA.BamHI (Table 2). Neither oipA nor the pCR4 vector contain a naturally occurring 
BamHI site. Once the BamHI site was inserted, plasmids were cut at the BamHI site to facilitate 
subsequent cloning of selecTable markers; chloramphenicol acetyl transferase (CAT) and rdxA.  
 The CAT-rdxA cassette was isolated as a BamHI fragment from pMM672 (Loh et al. 
2011) (Table 2), a gift from Drs. Mark McClain and Timothy Cover of Vanderbilt University 
Medical Center. Digestion reaction of the plasmid was run on an agarose gel, and the CAT-rdxA 
cassette was isolated by gel purification (IBI). Once isolated, the cassette was cloned into 
pOipA.BamHI using T4 ligase, facilitated by the presence of BamHI sites on both the linear 
pOipA.BamHI plasmid and the CAT-rdxA cassette. This new plasmid (pOipA::CAT-rdxA, Table 
2) was transformed into E. coli, selected for based on Cm resistance, isolated and purified. The 
presence of the cassette was confirmed with a PCR using the oipA universal primers and 
comparing the mutants to controls. This result was corroborated with sequencing as well.  
 Lastly, this oipA::CAT-rdxA plasmid was naturally transformed into the appropriate 
ΔrdxA strains of H. pylori (26695, J68, and J75 ΔrdxA) and selected for using SFBB plates with 
10µg Cm/mL. Resultant strains were confirmed via PCR of the oipA locus and sequencing, and 
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named according to transformed H. pylori strain and ΔrdxA/ oipA::CAT-rdxA (Table 3). These 
strains, (26695, J68, and J75 ΔrdxA/ oipA::CAT-rdxA), serve as both intermediates in the 
isolation of markerless mutants and as oipA knockouts, and are each MtzS and CmR.  
Cloning of oipA mutant plasmids  
 oipA mutagenic oligos were designed specific to each strain to alter the number of CT 
dinucleotide repeats in the 5’ region of oipA in order to turn the gene phase off in the cagPAI 
positive  H. pylori strain 26695, and phase on in the cagPAI negative H. pylori strains J68 and 
J75. This was accomplished by deleting one CT in strain 26695 to go from 6 CT repeats to 5, 
resulting in a frame shift in oipA from phase on to phase off, adding one CT in the J68 oipA 
allele from 10 to 11 dinucleotide repeats (oipA phase off to phase on), and deleting one CT in the 
J75 oipA allele from 7 to 6 to turn oipA from phase off to phase on. Sequences of wild type and 
mutant oipA in all three strains, as well as the corresponding amino acid sequence, are depicted 
in Figure 3. Mutagenesis was performed using the 26695.oipAOFF, J68.oipAON, and 
J75.oipAON mutagenic primers (Table 1), respectively, and several clones were screened via 
sequencing. Plasmids were named p26695.oipAOFF, pJ68.oipAON, and pJ75.oipAON (Table 2).  
 Confirmed clones were naturally transformed into the appropriate H. pylori strain ΔrdxA/ 
oipA::CAT-rdxA. Mutated oipA plasmids were able to recombine with the oipA::CAT-rdxA 
locus on the recipient chromosome to replace the CAT-rdxA cassette. Such allelic replacement 
mutants were selected for with SFBB plates containing 5µg metronidazole/mL. The loss of the 
CAT-rdxA cassette during allelic replacement leaves the strain with only a defective rdxA locus 
due to the earlier deletion in a location distant from the oipA gene on the genome. These strains, 
26695 ΔrdxA/oipAOFF, J68 and J75 ΔrdxA/oipAON (Table 3), are MtzR/CmS, and have a 
mutated oipA gene with no antibiotic resistance genes left behind in the same region.  
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Cloning of FLAG epitope mutant plasmids  
 In order to examine oipA expression beyond relative transcript levels, we aimed to 
observe protein expression at the whole cell level in the mutant strains using Western blotting. 
While creating an antibody specific to oipA was not feasible in the time frame of this honors 
project, we were able to design mutagenic primers containing a FLAG tag (Sigma-Aldrich) and 
insert this seven amino acid epitope encoding sequence into the gene oipA (Table 1). These 
primers were used in site-directed mutagenesis with 26695, J68, and J75 plasmids containing 
wild type oipA as well as mutant oipA. Successful plasmids were confirmed via sequencing and 
named with the appropriate strain and phase of oipA, i.e. p26695oipAOFF.FLAG (Table 2). 
Plasmids were naturally transformed into the appropriate H. pylori strain ΔrdxA/ oipA::CAT-
Strain  Sequence 
26695 WT phase on  ATGAAAAAAGCTCTCTTACTAACTCTCTCTCTCTCGTTCTGGCTCCACGC 
26695 phase on protein MKKALLLTLSLSFWLHAERNGFYLGLNFLEGSYIKGQGSIGKKASAENAL 
26695 phase off ATGAAAAAAGCTCTCTTACTAACTCTCTCTCT__CGTTCTGGCTCCACGC 
26695 phase off protein MKKALLLTLSLVLAPR*KEWILFRFKFSRRKLY*RTR*HRQKSFSRKRLK* 
J68 WT phase off ATGAAAAAAACTCTCTTACTCTCTCTCTCTCTCTCTCTCGTTTTGGCTCC 
J68 phase off protein MKKTLLLSLSLSLVLAPR*KERILFRFKFSRRKLYSRTR*HRQKSFSRKR 
J68 phase on  ATGAAAAAAACTCTCTTACTCTCTCTCTCTCTCTCTCTCTCGTTTTGGCT 
J68 phase on protein MKKTLLLSLSLSLSFWLHAERNGFYLGLNFLEGSYIQGQGSIGKKASAEN 
J75 WT phase off ATGAAAAAAGCCCTCTTACTAACTCTCTCTCTCTCTCGTTTTGGCTTCAC 
J75 phase off protein MKKALLLTLSLSRFGFTLKGTGFIWV*ILQKEAIFKDKAASAKKLQQKTP* 
J75 phase on ATGAAAAAAGCCCTCTTACTAACTCTCTCTCTCT__CGTTTTGGCTTCAC 
J75 phase on protein MKKALLLTLSLSFWLHAERNGFYLGLNFAEGSYIQGQGSIGKKASAENAL 
Figure 3. Sequences of oipA in H. pylori strains 26695, J68, and J75. DNA sequences begin with the 
start codon ATG, and corresponding amino acid sequences begin with methionine. Each sequence contains the 
first 50 base pairs or amino acids, respectively. Stop codons are depicted by *. The CT dinucleotide repeat 
tract is in italics, and changes to the tract in mutant strains are underlined.  
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rdxA and again confirmed with sequencing. These strains (Table 3) were later used in Western 
blotting using ANTI-FLAG antibodies (Sigma-Aldrich).  
Cloning of cagE KO mutant plasmids 
 In addition to altering the phase of oipA based on the presence or absence of the cagPAI, 
we also wanted to create an artificial cagPAI T4SS knockout in the naturally cagPAI positive 
strain 26695. Previous studies have shown that the most efficient way to accomplish this is to 
knockout one essential component of the cagPAI, cagE, which will render the type IV secretion 
system non-functional. A plasmid containing this knockout, pICB:CAT (Table 2), was created 
by Tummuru et al. (1995)by inserting a chloramphenicol resistance gene, CAT, into the gene 
cagE, previously named picB.  This plasmid was naturally transformed into both 26695 ΔrdxA 
with oipA unaltered and thus phase on, and 26695 ΔrdxA, oipA phase off. Clones with the 
mutation were selected for using SFBB plates with 10µg Cm/mL, and the CAT insertion within 
the chromosomal copy cagE was confirmed via PCR and Big Dye sequencing using the cagE 
Universal Fwd and Rev primers (Table 1). Strains were named 26695 oipAON.cagEKO and 
26695 oipAOFF.cagEKO (Table 3).  
Cloning of J75 5’ UTR indel deletion plasmids 
 In order to delete the 11bp indel in the 5’ UTR of J75, complementary primers were 
designed to match the sequence surrounding, but excluding, the indel. These J75 5’ UTR 
deletion mutagenic oligos (Table 1) were used in mutagenesis reactions using a QuikChange 
Lightning Site-Directed Mutagenesis System (Agilent Technologies) with pJ75.oipAON and 
pOipA.J75 as templates. Several clones were analyzed via DNA sequencing using the 
oipA.Fwd.J75 primer (Table 1). The successful plasmids were named pJ75.oipAOFF.5’Δ and 
pJ75.oipAON.5’Δ (Table 2). These plasmids were naturally transformed into J75 ΔrdxA/ 
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oipA::CAT-rdxA, and selected for using SFBB plates with 5µg Mtz/mL. Resultant strains were 
confirmed via PCR and sequencing, and named J75.oipAOFF.5’Δ and J75.oipAON.5’Δ (Table 
3).  
Plasmid Purification and Isolation 
5mL of liquid LB/100µg ampicillin ml-1 broth were inoculated with a single isolated E. 
coli colony from antibiotic plates or grown from freezer stock (LB + 30% glycerol). Liquid 
culture was incubated at 37°C shaking at 225rpm for 16-24hours. Cells were spun down at 5000 
xg. Cells were lysed and plasmids were isolated using Mini Hi-Speed Plasmid Kit (IBI). 
Concentrations of plasmid dsDNA were quantified using a NanoPhotometer (Implen).  
H. pylori Natural Transformation  
H. pylori strains desired to be transformed were grown up from freezer stock and passed 
to 4-6 BAPs to grow for 24-36 hours. All growth was harvested into 10mL of SFBB/10µg 
vancomycin ml-1 and centrifuged at 4360rpm for 5 minutes. The appropriate plasmid was heat 
sanitized at 80°C for 20 minutes to reduce potential contamination. Between 7-13µg of plasmid 
were added to resuspended H. pylori cells, and 30µL of the suspension was spotted onto the 
center of 5 BAPs, and incubated face up for 2-4 hours at standard conditions. Spots were 
streaked across the plates and incubated face down overnight. Each BAP was harvested and 
passed to its own SFBB plate with the desired antibiotic for selection. Plates were incubated for 
3-5 days. Individual colonies (4-7) were isolated and harvested from their own BAP for genomic 
DNA extraction.  
Genomic DNA Extraction  
 H. pylori was grown on BAPs for 24-48 hours under standard conditions. Cells were 
harvested in 1mL of Phosphate Buffered Saline (PBS) and centrifuged at 6,000 rpm for 5 
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minutes. gDNA extraction was performed via the Mini gBAC genomic DNA kit (IBI) by the 
manufacturer’s protocol.  
Amplified Fragment Length Polymorphism (AFLP) Analysis  
 AFLP was employed to determine natural variation in the oipA CT dinucleotide repeat 
tract of H. pylori grown in vitro. AFLP primers were designed to amplify a 270 bp PCR product 
beginning upstream of oipA and including the CT dinucleotide repeat tract (Table 1). Separate 
primers were designed to amplify a 294bp control region of the gene from a non-repeat bearing 
region to serve as a control. In each case, reverse primers contained fluorescent VIC tags on the 
5’ end (Applied Biosystems). Genomic DNA was obtained from desired strains of H. pylori. 
Each sample was assayed in triplicate in a PCR with the VIC tagged primers to amplify the 
desired regions of oipA, and amplicons were generated according to the manufacturer’s protocol. 
One µL of 1:50 diluted PCR samples were added to 12µL Hi-Di Formamide plus 0.25µL 
GeneScan Rox500 size standard in 96 well plates. Samples were denatured at 95°C for 3 minutes 
and analyzed with ABI 3130 genetic analyzer to quantify amplicon frequency. For each run, the 
individual area under the curve for each amplicon was summed to determine the total area.  
Attachment Assay 
 These assays were performed to quantify the ability of H. pylori to adhere to AGS cells, a 
cell line from human gastric adenocarcinoma. AGS cells were routinely cultured in T75 flasks 
containing sterile RPMI medium supplemented with 10% fetal bovine (FBS) or newborn calf 
serum (NCS) as well as HEPES (10mM) (Gibco) with penicillin and streptomycin. For 
adherence assays, each well of a 6-well tissue culture plate (Cyto One) was seeded with 2.5x105 
AGS cells and grown for 24 hours to reach 5x105 AGS cells per well. Wells were washed three 
times with RPMI supplemented with 10% FBS with no antibiotics. AGS cells were infected with 
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H. pylori at a multiplicity of infection of 100:1 (H. pylori: AGS) and incubated at standard 
conditions and 50rpm shaking for 5 hours. At 5 hours, culture medium was harvested for 
subsequent ELISA for IL-8, and wells were washed three times with PBS and then lysed with 
0.1% Saponin in PBS for 15 minutes at standard conditions and shaking. Lysates were collected 
and serially diluted in PBS to 10-7. Dilutions were plated on BAPs in 20 μL spots in triplicate and 
incubated at standard conditions for 5 days. After 5 days, colony forming units (CFU) were 
counted and bacterial titer calculated.  
Post-Attachment oipA expression  
 In order to determine oipA expression in H. pylori that had adhered to AGS cells as 
compared to those unattached in the supernatant, attachment assays were performed as above. 
After the 5 hour incubation, all 3mL of supernatant were collected from each well and 
centrifuged at 4360rpm, 4°C for 10 minutes. Supernatants were manually removed by pipetting, 
and the pellets were resuspended in 1mL of RNAzol RT (Molecular Research Center, Inc.). This 
preparation contains the non-adherent H. pylori cells.  The AGS monolayer containing attached 
H. pylori was then washed twice with PBS to remove non-attached bacteria, and lysed with 1mL 
of 0.1% saponin for 15 minutes at standard conditions. Cells were scraped and lysates were 
collected. Wells were washed twice with PBS. Lysates were centrifuged at 4360rpm, 4°C for 10 
minutes, supernatants were removed manually, and pellets were resuspended in 1mL of RNAzol 
RT. RNA was extracted, cDNA created, and samples used in RT-qPCR to quantify relative 
quantity of oipA transcript (see methods below).  
RNA Extraction 
 Preparation: H. pylori was grown from freezer stock. Samples were collected in 5mL of 
SFBB/ 10µg Vancomycin ml-1 at 0.2 OD600 and incubated at standard conditions, shaking at 
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150rpm for 12-24 hours. OD600 values were determined, and 8x108 cells were collected and 
centrifuged at 4360 rpm for 10 minutes at 4°C. Supernatants were discarded and cell pellets were 
suspended in 1mL of RNAzol RT (Molecular Research Center, Inc.). Total RNA was extracted 
from each pellet according to the manufacturer’s protocol. Suspensions were beadrupted for 45 
seconds. Molecular grade water was added to each sample and allowed to incubate for 15 
minutes. Samples were spun down for 15 minutes at 12,000 x g. 1mL of supernatant was added 
to 75% ethanol and incubated for 10 minutes. Samples were centrifuged at 10,000 xg for 8 
minutes and supernatant was decanted. Two additional ethanol washes were carried out and 
RNA pellets were allowed to dry for 20 minutes. Pellets were resuspended in 20-70 μL of PCR 
grade H2O. Samples were then transferred to ice and RNA concentrations quantified using a 
NanoDrop.  
RNA samples were then used in cDNA synthesis. 1 μg of purified RNA was combined 
with iScript Reverse Transcription Supermix for RT-qPCR (Bio-Rad) and cDNA was 
synthesized using the manufacturer’s cDNA synthesis protocol. cDNA was used for RT-qPCR. 
Real-Time Quantitative PCR (RT-qPCR)   
 The expression of the H. pylori gene oipA was compared to the housekeeping gene ftsZ 
and/or gyrB, encoding the cell division protein FtsZ and DNA gyrase subunit B, respectively, 
using a TaqMan Gene Expression assay (Life Technologies) performed on the Applied 
Biosystems StepOne apparatus. The assays were performed in technical triplicate for each gene 
and each strain according to the manufacturer’s protocol using custom TaqMan Custom Gene 
Expression assays (Thermo-Fisher), including the oipA.Taq, ftsZ.Taq, and gyrB.Taq probes 
(Table 1). Relative expression of genes among the various mutants was calculated using the 2∆∆Ct 
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method as described by Livak and Schmittgen (2001) and processed using DataAssist software 
(Applied Biosystems). 
Enzyme-Linked Immunosorbent Assay (ELISA)  
 Human IL-8 ELISA MAX Deluxe assays (BioLegend) were used via the manufacturer’s 
protocol in order to quantify the concentration of IL-8 produced by AGS cells in the presence 
and absence of H. pylori.  Adhesion assay culture media were centrifuged at 6000 rpm and 
supernatants were used in ELISA. A 96 well plate was coated in diluted human IL-8 capture 
antibody overnight at 4°C. After washing four times with wash buffer, assay diluent A was 
added and incubated for 1 hour. The plate was washed and diluted standards and sample 
supernatants were added, followed by incubation for 2 hours at room temperature (RT), shaking. 
The plate was washed and diluted detection antibody was added, and the plate was allowed to 
incubate for one hour at RT, shaking. After washing, Avidin-HRP was added and incubated for 
30 minutes at RT, shaking, followed by 5 washes with wash buffer, and then Substrate Solution 
C was added and the plate was allowed to incubate in the dark at RT for 15 minutes. Stop 
solution was added and the plate was read at an absorbance of 450nm on a Bio-Rad iMark 
Microplate Reader.  
Western Blot  
 Mutant and control strains of H. pylori were grown on blood agar plates, 0.4 OD600 units 
of cells were denatured and reduced, and total proteins were separated by SDS-PAGE. Proteins 
were transferred from the gel to nitrocellulose blotting membranes (Bio-Rad). Proteins were 
separated via western blot and OipA expression detected using Monoclonal ANTI-FLAG M2 
antibody (Sigma-Aldrich), followed by anti-mouse IgG-Peroxidase. Chemiluminescence was 
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accomplished using SuperSignal West Pico Chemiluminescent Substrate (Thermo Scientific) and 
visualized with X-Ray film.  
Results 
Phase Variation in the CT Repeat Tract of oipA is Rare in Strains Grown in vitro  
 Outer membrane inflammatory protein (OipA) has been shown to be phase “on” in 
cagPAI positive strains of H. pylori, and phase “off” in cagPAI negative strains, nearly without 
exception (Ando et al. 2002). As previously described, OipA expression is regulated via slipped-
strand mispairing in a CT dinucleotide repeat tract in the 5’ end of the gene. This hypermutable 
sequence can be used to generate phase variation in the gene. Typically, the longer the 
hypermutable sequence, the more likely that variation will occur (Harvey et al. 2014). In order to 
determine if there was natural variation in this CT repeat length when strains of H. pylori are 
grown in vitro, we employed amplified fragment length polymorphism (AFLP) analysis.  
Results shown in Figure 4 suggest that despite the ability of slipped strand mispairing in 
the CT tract to generate variability, there was little variation in the number of CT repeats present 
within populations of the tested H. pylori strains. In the cagPAI positive strain, 26695, >97% of 
the population contained 6 CT’s, creating a phase on allele of oipA. In the cagPAI negative H. 
pylori strain, J68, while the majority of the population is phase off with 8 CT’s, there is a more 
significant minority population, compared with strains 26695 and J75, that is phase on with 6 
CT’s, ~9% (Figure 4). In the cagPAI negative strain, J75, >95% of the population contained 7 
CT’s, making the oipA allele in this less virulent strain phase off. Overall, this apparent paucity 
of in vitro variation in the poly CT tract suggests that the relationship between the presence/ 
absence of the cagPAI and the expression phase of oipA tends to be well maintained.  
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Experimental Alterations to the CT Tract Result in Changes in oipA Expression  
 In order to quantify the effect of changes to the CT tract on oipA expression, RNA was 
isolated from the H. pylori oipA mutants and controls, converted to cDNA, and used in RT-qPCR 
to measure oipA transcript levels. Transcription and translation are coupled in bacteria, and 
transcription often undergoes rho dependent termination when translation halts. In prokaryotes, 
ribosomes begin translating mRNA emerging from RNA polymerase, but dissociate when they 
encounter a stop codon. Rho factor binds to sites on naked RNA, pulling the nascent RNA away 
Control 26695 (cagPAI pos.) J68 (cagPAI neg.) J75 (cagPAI neg.) 
 
  
 
97.5% phase on (6 CT) 
2.5% phase off  (5 CT) 
 
  
91.0% phase off (8 CT) 
9.0% phase on (7 CT) 
 
  
95.7% phase off (7 CT) 
4.3% phase on (6 CT) 
 
Figure 4. Amplified Fragment Length Polymorphism (AFLP) analysis of H. pylori oipA 
AFLP analysis was used to quantify variations in the oipA CT dinucleotide repeat tract in amplicons from 
H. pylori strains 26695, J68, and J75. The amplicon generated using primers oipA.AFLP.fwd and 
oipA.AFLP.rev (Table 1) is predicted to be 269bp in 26695, 274bp in J68, and 286bp in J75.   
290bp 269bp 274bp 286bp 
267bp 272bp 284bp 
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from RNA polymerase and the DNA template and thus terminating transcription (Boudvillain et 
al. 2013). Transcription termination in H. pylori is most likely rho dependent (Washio et al. 
1998). For example, if oipA is phase off due to the number of CT dinucleotide repeats, the 
mRNA will thus contain in-frame, cryptic stop codons which will cause ribosomes to dissociate 
from the emerging transcript, which will allow rho transcription terminators to catch up to RNA 
polymerase and stop transcription. Therefore, although oipA can be transcribed whether the gene 
is phase on or phase off, a cell that is phase off will not only have no protein, but will also have 
less mRNA transcripts. In this way, we have used RT-qPCR to indicate a relative rate of protein 
translation via the relative quantity of transcript (Acio-Pizzarello et al. 2017, in press).  
 Deleting the internal portion of rdxA in order to create a metronidazole resistant control 
within wild type, phase on oipA in strain 26695 did not produce a significant difference in oipA 
transcript levels compared to the wild type H. pylori strain by a Welch’s unpaired t-test of 
unequal variance, indicating that it is a reliable control (Figure 5). Altering the number of CT’s 
in oipA in 26695 such that the gene is phase off decreases the transcript levels of the gene by 
more than 80% compared to the phase on control. Additionally, the relative quantity of oipA 
transcript when the gene is phase off is not significantly different from the relative quantity when 
the gene is “knocked out” by insertion of a CAT-rdxA cassette, thus creating a null mutant 
(Figure 5).  
Similarly, there is no significant difference between the cagPAI negative J68 ΔrdxA 
control with oipA phase off, and the J68 oipA knock out created in the same manner (Figure 6). 
When the CT dinucleotide repeat tract was altered such that oipA was in frame and thus phase on 
in J68, there was a significant increase in oipA transcript levels (Figure 6), further indicating that 
changes to the CT tract lead to altered gene expression compared to the control.  
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Figure 5. Phase off status of oipA in H. pylori strain 26695 causes a significant decrease in 
the relative quantity of transcripts expressed.  
Real time quantitative PCR was used to determine the relative expression of oipA in the H. pylori 26695 
ΔrdxA control strain with oipA phase on, compared to wild type, as well as to the oipA phase off and oipA 
knock out mutants. The data shown here is representative of the results obtained in three independent 
experiments, each conducted in technical triplicate. Error bars show standard deviation. Statistics were 
calculated using a Welch’s unpaired t-test of unequal variance with 26695 oipA phase on as the control 
(** = p ≤ .01,  n.s. = p > .05). 	
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Phase On Status of oipA in the cagPAI Negative H. pylori Strain J68 Results in Expression 
of Full Length OipA Protein  
 Though RT-qPCR results indicated that oipA mRNA transcripts were at higher levels and 
thus potentially translated, we employed anti-FLAG western blots to see if the OipA protein was 
being expressed at the whole cell level. A FLAG protein epitope tag was inserted into the oipA 
allele of H. pylori strain J68 via site directed mutagenesis and allelic exchange, and a 
monoclonal antibody to this epitope was used to detect OipA protein in western blots. In the 
Figure 6. Phase on status of oipA in J68 leads to a significant increase in the relative quantity 
of oipA transcripts expressed.  
Real time quantitative PCR was used to determine the relative expression of oipA in the H. pylori J68 ΔrdxA 
control strain with oipA phase off, compared to wild type, as well as to the oipA phase on and oipA knock 
out mutants. The data shown here is representative of the results obtained in three independent experiments, 
each conducted in technical triplicate. Error bars show standard deviation. Statistics were calculated using a 
Welch’s unpaired t-test of unequal variance with J68 oipA phase off as the control (* = p ≤ .05,  n.s. = p > 
.05). 
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cagPAI negative and naturally oipA phase off H. pylori strain J68, when oipA was 
experimentally turned to phase on, there was an ~34 kDa protein detected (Figure 7).  This 
indicates a successful switch from phase off to on, and expression of the protein of the predicted 
size of OipA (34,184 Daltons) (performed by Allison Begley, our high school protégée, 2016).  
 
Phase On oipA Confers an Increased Host Adherence Phenotype  
Once it was demonstrated that altering the number of CT dinucleotide repeats resulted in 
successful phase change of oipA with a concomitant expression of the OipA protein, we next 
wanted to investigate whether the demonstrated decrease in oipA transcript level in the cagPAI 
positive strain 26695 (Figure 5) would lead to a decrease in H. pylori adherence to gastric 
epithelial cells, and vice versa in the cagPAI negative strain J68. When oipA was turned phase 
off in 26695, attachment levels decreased from ~1.0x105 CFU/mL to less than 2.0x104 CFU/mL 
(Figure 8). oipA phase was also strongly correlated to H. pylori attachment capability in J68, as 
attachment levels more than doubled when oipA was turned phase on  (Figure 9). These results 
indicate that OipA has the ability to mediate attachment to host cells independent of the cag 
pathogenicity island and demonstrate that the cagPAI negative strain J68 allele of oipA is fully 
functional when turned phase on.  
Figure 7. Phase on status of oipA in H. 
pylori strain J68 results in expression of 
the protein OipA. Anti-FLAG Western blots 
were performed on 0.4 OD600 units of A: J68 
oipA phase off control, B: J68 oipA phase on 
mutant, C: J68 oipA phase off with FLAG tag, 
D: J68 oipA phase on with FLAG tag (E and F 
are replicate results of C and D using 
independent oipA FLAG tagged H. pylori 
clones). There was a cross-reactive protein in 
all strains.  
  A       B        C        D        E         F 
~34 kDa 
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OipA Effects on IL-8 Production 
Due to the differences in attachment ability observed between H. pylori strains with oipA 
phase on and phase off, and given OipA’s theorized involvement in the host inflammatory 
response, we hypothesized that the attachment results might be associated with similar changes 
in epithelial cell IL-8 production. To quantify this in terms of IL-8 concentration, attachment 
assay culture medium was collected and the undiluted cell-free conditioned media were used to 
Figure 8. H. pylori strain 26695 attachment to 
host cells is reduced when oipA is turned phase 
off. Attachment assays were performed to determine 
whether oipA phase was important in 26695’s ability 
to adhere to AGS cells. Adhesion phenotypes 
depending on oipA status were compared. The data 
shown here is representative of the results obtained in 
independent experiments, each conducted in technical 
triplicate. Error bars show standard deviation. 
Statistics were calculated using a Welch’s unpaired t-
test of unequal variance (* = p ≤ 0.05).   
 
Figure 9. Strain J68 exhibits increased 
adherence ability when oipA is turned phase 
on. Attachment assays were performed to determine 
whether turning oipA phase on in the cagPAI negative 
strain J68 would alter the bacterium’s ability to adhere 
to AGS cells. Adhesion phenotypes depending on 
oipA status were compared. The data shown here is 
representative of the results obtained in five 
independent experiments, each conducted in technical 
triplicate. Error bars show standard deviation. 
Statistics were calculated using a Welch’s unpaired t-
test of unequal variance (* = p ≤ 0.05).  
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conduct IL-8 ELISAs in technical triplicate. AGS cells infected with the cagPAI positive strain 
26695 with oipA experimentally switched to phase off produced nearly 90% less IL-8 than those 
infected by H. pylori with oipA phase on (Figure 10). There was no significant difference in the 
amount of IL-8 produced by AGS cells infected with strain 26695 with oipA knocked out via the 
CAT-rdxA cassette as compared to oipA phase off, and both of these concentrations of IL-8 were 
comparable to the amount of IL-8 produced by uninfected AGS cells (Figure 10).  
 
Figure 10. Phase off status of oipA in H. pylori strain 26695 correlates with decreased 
adhesion and decreased gastric epithelial cell IL-8 production. Cell medium from AGS cells 
infected with 26695 oipA phase on, or oipA knock out, or oipA phase off H. pylori, as well as from 
uninfected AGS cells was collected after a 5 hour infection and used in ELISA to detect AGS cell IL-8 
production. IL-8 concentrations were compared. The data shown here is representative of the results 
obtained in three independent experiments, each conducted in technical triplicate. Error bars show 
standard deviation. Statistics were calculated using a Welch’s unpaired t-test of unequal variance (** = p 
≤ 0.01, n.s. = p > 0.05).  
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 Surprisingly, in H. pylori strain J68 there was no significant difference in IL-8 production 
by AGS cells, whether infected with oipA phase on, oipA phase off, oipA knock out strains, or 
uninfected (Figure 11). This stark contrast between cagPAI positive and cagPAI negative strains 
indicates that, while OipA has demonstrated the ability to mediate IL-8 production in the 
presence of the T4SS encoded by the cag pathogenicity island, OipA cannot itself alone mediate 
the host inflammatory response in the absence of the cagPAI.  
 
 
 
Figure 11. Increased adhesion via oipA phase on status in J68 does not affect gastric 
epithelial cell IL-8 production. Cell medium from AGS cells infected with J68 oipA phase off, or 
oipA knock out, or oipA phase on H. pylori, as well as from uninfected AGS cells was collected after a 5 
hour infection and used in ELISA to detect AGS cell IL-8 production. IL-8 concentrations were 
compared. The data shown here is representative of the results obtained in three independent experiments, 
each conducted in technical triplicate. Error bars show standard deviation. Statistics were calculated using 
a Welch’s unpaired t-test of unequal variance (n.s. = p > 0.05).  
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oipA mRNA Transcript Levels in Adherent vs. Non-adherent H. pylori  
 While the traditional attachment assays can provide information on attachment capability 
and IL-8 production, we also wanted to know if there was a difference in the amount of oipA 
mRNA transcripts in H. pylori that had attached to AGS cells, versus those that were also 
incubated with host cells, but remained unattached. In order to determine this, attachment assays 
were performed as before, however after the 5-hour incubation, whole infected AGS cell culture 
supernatants were collected separately, as were adherent H. pylori after lysing infected AGS 
cells. RNA was extracted from both the non-adherent H. pylori (those in the cell culture 
supernatants) samples as well as from cells bound to AGS cells.  cDNA was then synthesized, 
and RT-qPCR was used to quantify relative oipA expression.  
 Due to the variation in H. pylori cell numbers in these two populations and subsequently 
mRNA and cDNA amounts compared to traditional mRNA extraction preparations, two 
housekeeping genes were used in RT-qPCR experiments. ftsZ was used as a normalizing gene as 
per ususal, and gyrB was employed as a comparison to oipA. Relative quantities of the 
housekeeping gene gyrB are not predicted to vary due to H. pylori attachment or non-attachment 
to AGS cells.  
 Results from this experiment revealed that 26695 oipA phase on H. pylori cells that were 
attached to AGS cells after the 5 hour infection had 7 times the amount of oipA transcript 
compared to those cells that had not attached, while housekeeping gene gyrB transcript levels did 
not vary (Figure 12). This may indicate that there is selection occurring within the H. pylori 
population that confers an adherence advantage to H. pylori cells that produce more OipA; one 
hypothesis being that they could better adhere to host cells and avoid adverse effects such as 
mucosal layer shedding. Interestingly, this trend also holds for 26695 oipA phase off (Figure 12). 
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We hypothesize that this may be due to selection for phase on variants of oipA in the presence of 
AGS cells via the slipped strand mispairing mechanism. An alternative hypothesis is that contact 
with AGS cells may trigger increased transcription of oipA as a response to the presence of the 
gastric epithelium.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12. H. pylori that attach to AGS cells possess higher levels of oipA transcript. 
Attachment assays were performed using 26695 oipA phase on (panel A) and 26695 oipA phase off 
(panel B). For each infection, H. pylori in the supernatant was collected separately from the bacteria 
attached to the AGS monolayer. RNA was extracted, and cDNA synthesized was used in qPCR to 
determine relative quantities of oipA transcripts in attached cells compared to non-attached. The data 
shown here is representative of the results obtained in independent experiments, each conducted in 
technical triplicate. Error bars show standard deviation. Statistics were calculated using a Welch’s 
unpaired t-test of unequal variance (* = p ≤ 0.05, n.s. = p > 0.05). 
B A 
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oipA Status in the cagPAI Negative H. pylori Strain J75 does not Correlate to Increases in 
Transcript Levels 
 Despite the strong correlation between oipA phase on status and increased oipA mRNA 
transcript levels as well as AGS cell attachment ability in the cagPAI negative strain J68, turning 
oipA phase on in the cagPAI negative strain J75 did not lead to increased transcription of oipA 
(Figure 13) nor attachment (Figure 14). In fact, there was actually a slight decrease in attachment 
when oipA was phase on. Similarly to strain J68, oipA phase on status in J75 did not induce 
greater cytokine production by AGS cells (Figure 15). This is likely due to the documented lack 
of oipA mRNA response to experimental phase on conditions.  
 
 
 
 
 
 
Figure 13. Phase on status of oipA in J75 does not lead to increased oipA transcription, 
whether the 5’ UTR indel is deleted or not.  
Real time quantitative PCR was used to determine the relative expression of oipA in the H. pylori 
J75 control strain with oipA phase off, compared to oipA phase on and 5’ UTR deletion mutants. 
The data shown here is representative of the results obtained in two independent experiments, each 
conducted in technical triplicate. Error bars show standard deviation. Statistics were calculated using 
a Welch’s unpaired t-test of unequal variance with J75 oipA phase off as the control (n.s. = p > .05). 	
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Figure 15. oipA phase on status in J75 does not affect gastric epithelial cell IL-8 production. 
Cell medium from AGS cells infected with J75 oipA phase off, or oipA knock out, or oipA phase on H. 
pylori, as well as from uninfected AGS cells was collected after a 5 hour infection and used in ELISA to 
detect AGS cell IL-8 production. IL-8 concentrations were compared. The data shown here is 
representative of the results obtained in independent experiments, each conducted in technical triplicate. 
Error bars show standard deviation. Statistics were calculated using a Welch’s unpaired t-test of unequal 
variance (n.s. = p > 0.05). 
Figure 14. Phase on status of 
oipA in J75 leads to decreased 
attachment to AGS cells.  
Attachment assays were performed to 
determine whether turning oipA phase 
on in the cagPAI negative strain J75 
would alter the bacterium’s ability to 
adhere to AGS cells. Adhesion 
phenotypes depending on oipA status 
were compared. The data shown here 
is representative of the results obtained 
in three independent experiments, each 
conducted in technical triplicate. Error 
bars show standard deviation. 
Statistics were calculated using a 
Welch’s unpaired t-test of unequal 
variance (n.s. = p > 0.05). 
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Based on oipA expression results, we 
decided to further investigate the potentially 
unique nature of oipA in the cagPAI 
negative H. pylori strain J75 as compared to 
its cagPAI negative counterpart in the study, 
J68, and the cagPAI positive strain 26695. 
Aligned sequences of the promoters, 5’ 
untranslated regions (UTRs), and 5’ ends of 
oipA (Figure 16) revealed an 11bp indel in 
J75 amidst this highly conserved region 
(disregarding the known variation in the CT 
tract). Upon further investigation, we discovered that this indel was not unique to J75, but can be 
found in several sequenced strains of H. pylori, although still a minority (data not shown).  
 We hypothesized that this indel within the 5' UTR of oipA may be the reason that oipA 
transcripts are not produced at higher levels, even when the CT tract is altered such that the gene 
is phase on. To pursue the role of this 11bp indel, we deleted it in both H. pylori strain J75 
possessing a wild type phase off oipA, and in the mutant strain J75 possessing a phase on oipA. 
These strains were then used in RT-qPCR to determine whether or not H. pylori J75 would 
transcribe oipA at higher levels when the CT tract is altered to make the gene phase on, and the 
indel is no longer present. Interestingly, we found that despite the deletion of the indel, there was 
still no increase in the relative quantity of oipA expressed in J75 (Figure 13). This result further 
demonstrates the tight control J75 employs to avoid oipA expression, despite the fact that the 
gene is highly conserved.  
Figure 16. Comparison of oipA promoters, 5’ 
UTR, and 5’ region. Sequences of A: 26695, B: 
J68, and C: J75 were compared using a ClustalW 
alignment. J75 has a unique 11 base pair 5’ UTR 
indel not present in 26695 nor J68. 
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Discussion 
 OipA and the cag pathogenicity island are two well documented H. pylori virulence 
factors. The cagPAI encodes a type IV secretion system (T4SS) that induces the production of 
pro-inflammatory cytokines by host gastric epithelial cells (Khatoon et al. 2017). OipA acts as an 
adhesin, and also plays a role in the pro-inflammatory response (Oleastro & Ménard 2013). 
Studies have shown that cagPAI positive strains of H. pylori contain an oipA allele that is phase 
on while cagPAI negative strains contain a phase off, yet highly conserved, allele of oipA 
(Matsuo et al. 2017; Ando et al. 2002). Despite this finding and despite the importance of both 
virulence factors, the relationship between OipA and the cagPAI remains somewhat mysterious. 
The goal of my honors research project is to shed light on this relationship by observing the 
effects of mutating oipA to phase off status in cagPAI positive strain 26695, and mutating oipA 
to phase on in cagPAI negative strains J68 and J75.  
 Phase variation in OipA is regulated by a slipped strand mispairing mechanism affecting 
a CT dinucleotide repeat tract within the 5’ end of the gene (Miftahussurur & Yamaoka 2015). 
Despite this ability, our amplified fragment length polymorphism (AFLP) results suggest that 
there is little variation in the CT tract length in populations of H. pylori grown in vitro. This 
indicates that, while possible, phase variation at this locus may be rare. This is in contrast to 
phase variation in several other outer membrane proteins, including sialic acid binding adhesin 
(SabA) (Harvey et al. 2014), in which there are distinct subpopulations with varying CT tract 
lengths within a population. Over 80% of bacterial genomes are comprised of sequences 
encoding proteins. Additionally, when bacterial species transition to permanent host interactions, 
they undergo a major loss of genes, usually along the lines of the “use it or lose it” paradigm 
(Moran 2002). This occurs as species obtain metabolic compounds from the host and gradually 
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discard corresponding pathways and genes, resulting in small genomes comprised of the bare 
essentials. These factors add intrigue to the conundrum that phase off alleles of oipA are nearly 
always found in cagPAI negative strains of H. pylori (Ando et al. 2002), yet these strains have 
not lost the gene for this protein that is apparently never expressed. 
In silico corrections revealed that the protein produced when the CT tract is altered to 
generate a phase on allele of oipA in the cagPAI negative strains used in this study, J68 and J75, 
share >95% amino acid identity with the protein produced by 26695. Based on this finding, we 
hypothesized that turning oipA phase on in cagPAI negative strains of H. pylori would lead to an 
increase in oipA expression, would result in the production of a full length protein, and would 
lead to an improved ability of these cells to adhere to gastric adenocarcinoma (AGS) cells and to 
elicit pro-inflammatory cytokine (IL-8) production in these cells.  
 Real time quantitative PCR (RT-qPCR) experiments using oipA TaqMan probes showed 
that oipA transcript levels were significantly increased when oipA was phase on in both a cagPAI 
positive and a cagPAI negative strain of H. pylori, and decreased oipA transcript levels were 
significantly associated with phase off status. The increase in oipA mRNA transcript levels in H. 
pylori strain J68 correlated with anti-FLAG western blot detection of OipA::FLAG when the 
gene was turned phase on, indicating that this cagPAI negative strain is capable of expressing a 
full length OipA protein. Phase on oipA confers an advantage in host adherence ability in both 
cagPAI positive and negative strains as well, with a significant decrease in the number of H. 
pylori cells that were able to adhere to AGS cells when oipA was phase off. These findings show 
that OipA has the ability to mediate host attachment independent of the cag pathogenicity island.  
 IL-8 assay results from AGS infection experiments show that phase off status of oipA in 
the cagPAI positive strain 26695 correlates not only with a decrease in host attachment, but also 
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with decreased host production of this pro-inflammatory cytokine. It is striking that in the 
absence of OipA expression, there is a significant decrease in IL-8 production even in the 
presence of a functional cagPAI encoded T4SS. This indicates that the cagPAI cannot mediate 
IL-8 induction independent of OipA. This finding is also supported by the fact that OipA 
expression does not support any significant IL-8 secretion by AGS cells when infected by the 
cagPAI negative strain J68 with oipA experimentally turned phase on. We hypothesize that OipA 
works in conjunction with the cagPAI to induce the host inflammatory response, and that both H. 
pylori surface structures must be present to stimulate host pro-inflammatory cytokine production.  
 Post-infection RT-qPCR experiments where AGS cells were infected by H. pylori strain 
26695 revealed that there was a significant increase in the quantity of oipA mRNA transcripts in 
the H. pylori cells adhered to AGS cells, compared with those incubated with AGS cells, but that 
were non-adherent. We propose two alternative hypotheses regarding these results. First, we 
propose that there may be selection within the population of H. pylori used in the infection that 
allows cells expressing OipA to better adhere to host cells. This might also indicate that there is 
greater phase variation in systems including host cells. Further experiments could analyze this by 
performing AFLP on the adherent and non-adherent cell populations and quantifying the number 
of CT repeats in the gene oipA, and thus the expression phase of this adhesin. Selection 
experiments could also be employed in which adherent and non-adherent bacteria are isolated, 
cultured, and used in subsequent infections. Changes in attachment rates may indicate that it is 
possible to select for specific expression phases of oipA.  
An alternative hypothesis is that contact with AGS cells may trigger increased 
transcription of oipA as a response to the presence of the gastric epithelium. This hypothesis is 
supported by data showing the same increase in oipA transcript levels in attached cells compared 
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to non-attached, even when oipA is phase off in 26695. Both hypotheses are supported by the 
difficulties H. pylori faces in the stomach regarding mucosal shedding, which ultimately favors 
mechanisms allowing cells to “stick” to the gastric epithelium (Oleastro & Ménard 2013). 
 Correlations between oipA phase, mRNA transcript levels, and AGS cell attachment 
levels observed in H. pylori cagPAI negative strain J68 were not observed in a second cagPAI 
negative strain, J75. Phase on status of oipA in J75 had no effect on oipA mRNA transcript 
levels, nor did it result in increased attachment to AGS cells in vitro nor alter IL-8 levels. We 
hypothesize that this failure to increase transcript levels or attachment ability is due to the fact 
that the OipA protein is not expressed, even in the oipA phase on H. pylori J75 mutant. In fact, 
there was a decrease in the amount of AGS cell attachment when oipA was altered to phase on 
status in J75, compared to the phase off control. We hypothesized that the lack of oipA 
expression was due to an 11bp indel within the 5’ untranslated region (UTR) of the J75 allele of 
oipA, absent in either of the other strains used in this study, which may block or otherwise 
impede transcription or translation. However, when this indel was deleted, there was no apparent 
change in oipA expression.  
This result is puzzling as, with the exception of this 5’ UTR indel deletion, the J75 allele 
of oipA is remarkably similar to oipA alleles in the other two strains observed in the study, in 
which oipA phase changes had demonstrable phenotypic effects.  Taken with the unexpected 
AGS cell attachment data in which a phase on allele of oipA may actually cause a decrease in 
AGS cell adherence ability, these results suggest that expression of oipA may be under negative 
selection in J75. It is possible that oipA, when phase on, causes a decrease in fitness in this strain 
lacking the cagPAI when exposed to host cells. We hypothesize that another genetic defect in 
strain J75 may drive this inability to express oipA. Further study comparing the genomes of 
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strains J68 and J75 may reveal candidate loci that exert control over OipA expression.  This may 
be an occurrence that may allow us to identify a control mechanism for the expression of this 
important virulence factor. It may also whether or not regulatory sequences for oipA affect other 
genes in H. pylori; thus explaining its conservation in an alternate way.  
 The discovery that a phase on allele of oipA is able to produce the protein in a cagPAI 
negative strain of H. pylori, which always has the gene present but in a phase off status, and can 
mediate attachment, only begins to answer the question of why the gene is highly conserved if it 
is not expressed. This question is even more puzzling in J75, where a phase on status of oipA 
does not result in higher transcription levels or increased gastric cell attachment. Results from 
this study indicate that if cagPAI negative strains of H. pylori were to express OipA, the protein 
would be able to mediate host cell attachment, but not the host inflammatory response. Selection 
against expression of OipA should lead to the accumulation of mutations in the gene, and even 
its deletion.  We hypothesize that the expression of OipA must be important under a certain set 
of circumstances during host infection, otherwise we would expect to see evidence of decay and 
even removal of the gene, rather than persistent conservation in the absence of apparent 
expression. Future experiments could observe oipA mRNA transcript levels in adherent versus 
non-adherent cells from AGS cell attachment assays using the cagPAI negative strain J68 with 
varying phases of oipA, rather than the cagPAI positive strain 26695. This data may shed light 
OipA expression at varying points in infection in this cagPAI negative strain of H. pylori.  
 These experiments demonstrated changes due to oipA phase in strains of H. pylori that 
naturally possess or do not possess the cag pathogenicity island. A continuing study in our lab 
examines the effect of changes to the phase of oipA in 26695 possessing a defective allele of 
cagE (cagE::CAT). CagE, formerly PicB, is one protein encoded by the cagPAI, and is required 
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for induction of IL-8 in gastric epithelial cells (Tummuru et al. 1995). We generated a null 
mutant of CagE, which others have shown is incapable of assembling the T4SS and is thus 
unable to induce IL-8. We are currently working on creating these knock out strains in 26695 
with both expression phases of oipA, and will proceed to AGS cell attachment and IL-8 assays. 
Our hypothesis is that, without a functional cagPAI T4SS, H. pylori strain 26695 will be unable 
to induce IL-8 secretion no matter the expression phase of oipA.  
 Lastly, an interesting phenomenon discovered by our lab is that some strains of H. pylori, 
particularly those from East Asian patients, possess two copies of the oipA gene and are thus 
merodiploids. We have begun to analyze the role of the second copy of oipA, which is especially 
fascinating to us due to the fact that H. pylori infected patients from East Asian countries are 
more likely to develop gastric cancer. We have created a strain of 26695 that contains a second 
copy of oipA in the same location as the second copy in the Japanese strains 98-40 and 98-19. 
Another student in our lab, Kexin Fan, is currently working on creating mutants in strain 98-40 
where both copies of oipA are knocked out together and separately. She will continue this study 
to determine what purpose this second copy of oipA may have in more virulent strains of H. 
pylori.  
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Table 1: Primers used in this study 
Primer name  5’ to 3’ sequence  
HP0955 Fwd TGTAGGCATTCGTGGGATGAGC [Anneal: 56°C, 2min ext.] 
HP0953 Rev GCTCGGACTCATGGAATTGCTCCAT 
iPCR rdxA Fwd    PO4-CCTAAAATCGCATGCTTGATCGC [Anneal: 55°C, 6min ext.] 
iPCR rdxA Rev      PO4-GCGTGTTGTAAGAGCTTGGCG 
oipA universal Fwd CCATAAGGCATAAGACCTGAC [Anneal: 49°C, 3min ext.] 
oipA universal Rev GCAAGACAGCACCACTTTAGCCG 
oipA.fwd.1 GGCACATTCGCCCCACAAGCGCT [Anneal: 57°C, 2min ext.] 
oipA.rev.1 TCCATGCCAATCACAAGCCCTGA 
oipA BamHI FWD mut.   AGCATCGGCAAAAAAGGATCCGCAGAAAACGCCTTAAAT 
oipA BamHI REV mut. ATTTAAGGCGTTTTCTGCGGATCCTTTTTTGCCGATGCT 
26695 oipA OFF mut. GCTCTCTTACTAACTCTCTCTCTCGTTCTGGCTCCACGCTG 
J68 oipA ON mut. ACTCTCTTACTCTCTCTCTCTCTCTCGTTTTGGCTCCACGCTG 
J75 oipA ON mut. GCCCTCTTACTAACTCTCTCTCTCTCGTTTTGGCTTCACGCT 
oipA Flag Tag 1 mut.  ATTAATTGGACTAACGATTATAAAGATGATGATAAAGATAA
ACGAGCGTCC 
cagE Uni-Fwd GTGCTTGTAGCTCTTGGATTC 
cagE Uni-Rev TGCTTCTCATTATAGGCTCGC 
J75.5’UTR. Δ.Fwd mut. ATCAAATCTTAAACCAAAGAGAAACCATGA 
J75.5’UTR. Δ.Rev mut. TCATGGTTTCTCTTTGGTTTAAGATTTGAT 
oipA.Fwd.J75 GAGAGGTGAGCGGATTGGCTGGG [Anneal: 54°C, 2min ext.] 
oipA.Rev.J75 TCCTTGCAACTGAAAAATCGTGC 
oipA.AFLP.fwd ATTCATTAAGCTTTTGTGGCT [Anneal: 45°C, 30sec ext.] 
oipA.AFLP.rev VICAAGGCGTTTTCTGCTGAAGCT 
oipA.AFLP.control.fwd AGGGCTTGTGATTGGCATGGAAC [Anneal: 45°C, 30sec ext.] 
oipA.AFLP.control.rev VICATATGTATAGTTAAGATAAACGC 
oipA Consensus.Taq. Fwd GGCAGAACGCTAGACGCTAA 
oipA Consensus.Taq. Rev CCCCTAGTTCCATGCCAATCAC 
oipA Consensus.Taq FAM—AAGCCCTGAAGATTTT – MGB-NFQ  
ftsZ.Taq. Forward TGAGCGGCATTTCTACGATTATCAC 
ftsZ.Taq. Reverse CGCTCTTTAAATCGGCAAAATCAAC 
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ftsZ.Taq FAM – CAAACCCGGTAATATC – MGB-NFQ 
gyrB Consensus.Taq. Fwd AAAGCCAGAGAGCTTACAAGGAAAA 
gyrB Consensus.Taq. Rev CGCCCTCCACTAAAAAGATTTCACT 
gyrB Consensus.Taq FAM -- TTGCCTGGAAAATTAG– MGB-NFQ 
 
Table 2: Plasmids used or created for this study  
Name Description 
prdxA TOPO TA cloning vector pCR4 containing a1556 bp amplicon of the H. 
pylori strain 26695 rdxA gene  
pΔrdxA prdxA with a 390bp deletion in the rdxA gene 
pOipA (26695, J68, and 
J75) 
TOPO TA cloning vector pCR4 containing a 2300bp amplicon 
including the entire oipA gene, as well as the untranslated regions both 
upstream and downstream 
pOipA.BamHI (26695, 
J68, and J75) 
pOipA containing a BamHI site in the cloned allele of oipA 
pMM672 H. pylori 26695 plasmid in which the coding region of rdxA is deleted 
(Loh et al. 2011) 
pOipA::CAT-rdxA 
(26695, J68, and J75) 
pOipA.BamHI with CAT-rdxA cassette cloned into the BamHI 
restriction site 
p26695.oipAOFF pOipA 26695 with CT repeat tract consisting of 5 CT repeats 
pJ68.oipAON pOipA J68 with CT repeat tract consisting of 11 CT repeats 
pJ75.oipAON pOipA J75 with CT repeat tract consisting of 6 CT repeats  
p26695oipAOFF.FLAG p26695.oipAOFF containing a FLAG tag 
p26695oipAON.FLAG pOipA 26695 containing a FLAG tag 
pJ68oipAON.FLAG pJ68.oipAON containing a FLAG tag 
pJ68oipAOFF.FLAG pOipA J68 containing a FLAG tag 
pJ75oipAON.FLAG pJ75.oipAON containing a FLAG tag 
pJ75oipAOFF.FLAG pOipA J75 containing a FLAG tag 
pICB:CAT Plasmid containing the cagPAI, including cagE with CAT inserted 
(Tummuru et al. 1995) 
pJ75.oipAOFF.5’Δ  pOipA J75 with an 11bp deletion in the 5’ UTR 
pJ75.oipAON.5’Δ pJ75.oipAON with an 11bp deletion in the 5’ UTR 
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Table 3: H. pylori strains used or created for this study 
Name Description 
26695 Wild Type MtzS and CmS, contains oipA with a CT repeat tract consisting of 6 CT 
repeats (phase on)  
J68 Wild Type  MtzS and CmS, contains oipA with a CT repeat tract consisting of 10 CT 
repeats (phase off) 
J75 Wild Type  MtzS and CmS, contains oipA with a CT repeat tract consisting of 7 CT 
repeats (phase off) 
ΔrdxA (26695, J68, and 
J75) 
26695, J68, and J75 WT containing a 390bp deletion in the rdxA gene. 
MtzR and CmS 
ΔrdxA/ oipA::CAT-rdxA 
(26695, J68, and J75) 
26695, J68, and J75 ΔrdxA containing the oipA::CAT-rdxA construct. 
MtzS and CmR 
26695 ΔrdxA/oipAOFF 26695 ΔrdxA containing mutant oipA with a CT repeat tract consisting 
of 5 CT repeats (phase off). MtzR and CmS 
J68 ΔrdxA/oipAON J68 ΔrdxA containing mutant oipA with a CT repeat tract consisting of 
11 CT repeats (phase on). MtzR and CmS 
J75 ΔrdxA/oipAON J75 ΔrdxA containing mutant oipA with a CT repeat tract consisting of 6 
CT repeats (phase on). MtzR and CmS 
26695oipAOFF.FLAG 26695 ΔrdxA/oipAOFF containing a FLAG tag in oipA. MtzR and CmS 
26695oipAOFF.FLAG 26695 ΔrdxA containing a FLAG tag in oipA. MtzR and CmS 
J68oipAON.FLAG J68 ΔrdxA/oipAON containing a FLAG tag in oipA. MtzR and CmS 
J68oipAOFF.FLAG J68 ΔrdxA containing a FLAG tag in oipA. MtzR and CmS 
J75oipAON.FLAG J75 ΔrdxA/oipAON containing a FLAG tag in oipA. MtzR and CmS 
J75oipAOFF.FLAG J75 ΔrdxA containing a FLAG tag in oipA. MtzR and CmS 
26695 oipAON.cagEKO  26695 ΔrdxA containing cagE with CAT inserted. MtzR and CmR 
26695 oipAOFF.cagEKO 26695 ΔrdxA/oipAOFF containing cagE with CAT inserted. MtzR and 
CmR 
J75.oipAOFF.5’Δ  J75 ΔrdxA containing oipA phase off with an 11bp deletion in the 5’ 
UTR. MtzR and CmS 
J75.oipAON.5’Δ J75 ΔrdxA containing oipA phase on with an 11bp deletion in the 5’ 
UTR. MtzR and CmS 
 
